Other Viruses Citation List: December 20, 2013 - January 2, 2014
Hepatitis B Virus
1. Cyclosporin A and Its Analogs Inhibit Hepatitis B Virus Entry into Cultured Hepatocytes through Targeting a Membrane Transporter NTCP. Watashi, K., A. Sluder, T. Daito, S. Matsunaga, A. Ryo, S. Nagamori, M. Iwamoto, S. Nakajima, S. Tsukuda, K. Borroto-Esoda, M. Sugiyama, Y. Tanaka, Y. Kanai, H. Kusuhara, M. Mizokami, and T. Wakita. Hepatology, 2013. [Epub ahead of print]; PMID[24375637].
[PubMed] OV_1220-010214.
2. 2-Amino-N-(2,6-dichloropyridin-3-yl)acetamide Derivatives as a Novel Class of HBV Capsid Assembly Inhibitor. Cho, M.H., H. Jeong, Y.S. Kim, J.W. Kim, and G. Jung. Journal of Viral Hepatitis, 2013. [Epub ahead of print]; PMID[24372792].
[PubMed] OV_1220-010214.
3. Antiviral Activity of Chemical Compound Isolated from Artemisia morrisonensis against Hepatitis B Virus in Vitro. Huang, T.J., S.H. Liu, Y.C. Kuo, C.W. Chen, and S.C. Chou. Antiviral Research, 2014. 101: p. 97-104; PMID[24269476].
[PubMed] OV_1220-010214.
Hepatitis C Virus
4. Inhibitory Effects of Caffeic acid Phenethyl Ester Derivatives on Replication of Hepatitis C Virus. Shen, H., A. Yamashita, M. Nakakoshi, H. Yokoe, M. Sudo, H. Kasai, T. Tanaka, Y. Fujimoto, M. Ikeda, N. Kato, N. Sakamoto, H. Shindo, S. Maekawa, N. Enomoto, M. Tsubuki, and K. Moriishi. Plos One, 2013. 8(12): p. e82299; PMID[24358168].
[PubMed] OV_1220-010214.
5. Inhibition of Hepatitis C Virus Replication in Vitro by Xanthohumol, a Natural Product Present in Hops. Lou, S., Y.M. Zheng, S.L. Liu, J. Qiu, Q. Han, N. Li, Q. Zhu, P. Zhang, C. Yang, and Z. Liu. Planta Medica, 2013. [Epub ahead of print]; PMID[24356905].
[PubMed] OV_1220-010214.
6. Nucleotide Prodrugs of 2'-Deoxy-2'-spirooxetane Ribonucleosides as Novel Inhibitors of the HCV NS5B Polymerase. Jonckers, T.H., K. Vandyck, L. Vandekerckhove, L. Hu, A. Tahri, S. Van Hoof, T.I. Lin, L. Vijgen, J.M. Berke, S. Lachau-Durand, S. Bart, L. Leclercq, G. Fanning, B. Samuelsson, M. Nilsson, A. Rosenquist, K. Simmen, and P. Raboisson. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[24345201].
[PubMed] OV_1220-010214.
7. Discovery of Small Molecule Modifiers of MicroRNAs for the Treatment of HCV Infection. Tripp, V.T. and D.D. Young. Methods in Molecular Biology, 2014. 1103: p. 153-163; PMID[24318893].
[PubMed] OV_1220-010214.
8. Optimization of Potency and Pharmacokinetics of Tricyclic Indole Derived Inhibitors of HCV NS5B Polymerase. Identification of Ester Prodrugs with Improved Oral Pharmacokinetics. Venkatraman, S., F. Velazquez, S. Gavalas, W. Wu, K.X. Chen, A.G. Nair, F. Bennett, Y. Huang, P. Pinto, Y. Jiang, O. Selyutin, B. Vibulbhan, Q. Zeng, C. Lesburg, J. Duca, L. Heimark, H.C. Huang, S. Agrawal, C.K. Jiang, E. Ferrari, C. Li, J. Kozlowski, S. Rosenblum, N.Y. Shih, and F.G. Njoroge. Bioorganic & Medicinal Chemistry, 2014. 22(1): p. 447-458; PMID[24275348].
[PubMed] OV_1220-010214.
EBV
9. Potential Antiviral Lignans from the Roots of Saururus chinensis with Activity against Epstein-Barr Virus Lytic Replication. Cui, H., B. Xu, T. Wu, J. Xu, Y. Yuan, and Q. Gu. Journal of Natural Products, 2013. [Epub ahead of print]; PMID[24359277].
[PubMed] OV_1220-010214.
HSV1
10. Inhibition of Ataxia telangiectasia Mutated (ATM) Kinase Suppresses Herpes Simplex Virus Type 1 (HSV-1) Keratitis. Alekseev, O., K. Donovan, and J. Azizkhan-Clifford. Investigative Ophthalmology & Visual Science, 2013. [Epub ahead of print]; PMID[24370835].
[PubMed] OV_1220-010214.
11. Kay-2-41, a Novel Nucleoside Analogue Inhibitor of Orthopoxviruses in Vitro and in Vivo. Duraffour, S., R. Drillien, K. Haraguchi, J. Balzarini, D. Topalis, J.J. van den Oord, G. Andrei, and R. Snoeck. Antimicrobial Agents and Chemotherapy, 2014. 58(1): p. 27-37; PMID[24126587].
[PubMed] OV_1220-010214.
12. Study of Interferon-Beta Antiviral Activity against Herpes Simplex Virus Type 1 in Neuron-enriched Trigeminal Ganglia Cultures. Low-Calle, A.M., J. Prada-Arismendy, and J.E. Castellanos. Virus Research, 2013. [Epub ahead of print]; PMID[24374267].
[PubMed] OV_1220-010214.
Citations from the ISI Web of Knowledge Listings for O.V.
13. Molecular Design and Synthesis of HCV Inhibitors Based on Thiazolone Scaffold. Al-Ansary, G.H., M.A.H. Ismail, D.A. Abou El Ella, S. Eid, and K.A.M. Abouzid. European Journal of Medicinal Chemistry, 2013. 68: p. 19-32; ISI[000326902300003].
[WOS] OV_1220-010214.
14. Anti-Hepatitis C Virus RdRp Activity and Replication of Novel Anilinobenzothiazole Derivatives. Peng, H.K., W.C. Chen, Y.T. Lin, C.K. Tseng, S.Y. Yang, C.C. Tzeng, J.C. Lee, and S.C. Yang. Antiviral Research, 2013. 100(1): p. 269-275; ISI[000328179300030].
[WOS] OV_1220-010214.